The Mycotoxin Testing Market size was estimated at USD 2.88 billion in 2025 and expected to reach USD 3.09 billion in 2026, at a CAGR of 7.93% to reach USD 4.93 billion by 2032.

Mycotoxin testing is a critical food safety, feed safety, and trade assurance function because toxins such as aflatoxins, ochratoxin A, fumonisins, deoxynivalenol, zearalenone, T-2/HT-2 toxins, and patulin can enter supply chains through cereals, oilseeds, nuts, dried fruits, spices, coffee, milk, and animal feed. The World Health Organization recognizes mycotoxins as naturally occurring toxic compounds produced by molds, while Codex Alimentarius, the U.S. FDA, and the European Commission set or reference limits for key commodities.

Demand for reliable mycotoxin analysis is rising as global sourcing, climate variability, and stricter import controls increase the need for validated screening and confirmatory methods. Laboratories and manufacturers are prioritizing LC-MS/MS, HPLC, ELISA, lateral flow assays, immunoaffinity cleanup, and accredited quality systems to reduce recalls, protect consumers, and maintain market access.

The mycotoxin testing landscape is shifting from reactive batch testing toward preventive, risk-based surveillance across farms, storage, processing, and import checkpoints. Climate-linked changes in temperature, rainfall, drought stress, and pest pressure are influencing fungal growth patterns, making historical contamination maps less reliable for commodities such as maize, wheat, peanuts, tree nuts, and spices.

Regulatory convergence is also reshaping the market. The European Union’s contaminant framework, U.S. FDA action levels, Codex guidance, and national feed rules are pushing food businesses to document sampling plans, validated analytical methods, and traceable corrective actions. At the same time, buyers increasingly require multi-mycotoxin panels because co-occurrence is common in grains and feed ingredients, especially when weather and storage conditions favor multiple fungal species.

Artificial intelligence is beginning to compound the value of mycotoxin testing by connecting weather data, crop phenology, storage conditions, historical test results, and supplier performance into predictive risk models. Instead of relying only on end-product testing, AI-enabled systems can help identify high-risk lots, optimize sampling intensity, and prioritize confirmatory analysis where the probability of contamination is highest.

In laboratories, machine learning can support chromatographic peak review, spectral interpretation, anomaly detection, and LIMS-driven workflow optimization. AI does not replace validated analytical chemistry or regulatory decision-making, but it can reduce turnaround time, improve consistency, and help quality teams convert fragmented test records into early-warning intelligence for aflatoxin, DON, fumonisin, and ochratoxin control.

Asia-Pacific is a high-priority region because rice, maize, wheat, peanuts, spices, and feed ingredients move through complex domestic and export supply chains. China, India, Japan, South Korea, Australia, and ASEAN markets are strengthening surveillance as food safety modernization and export compliance expand. North America remains defined by advanced laboratory infrastructure, FDA action levels, USDA grain inspection practices, and strong testing demand from grain, dairy, pet food, and feed sectors.

Latin America is central to global mycotoxin testing because Brazil, Mexico, and other agricultural exporters supply maize, soy, peanuts, coffee, and animal feed ingredients to international markets. Europe maintains one of the most rigorous compliance environments through harmonized EU contaminant rules and frequent border controls. The Middle East relies heavily on imported cereals, nuts, spices, and feed, increasing demand for port-of-entry testing, while Africa faces significant public health and food security concerns from aflatoxin exposure in maize and groundnuts, making affordable rapid testing and capacity building essential.

ASEAN countries are expanding food export certification and import monitoring for rice, spices, seafood feed, and processed foods, with mycotoxin testing increasingly embedded in HACCP and supplier approval programs. The GCC is import-dependent for cereals, nuts, spices, and animal feed, making rapid port testing and conformity assessment important for food security and regulatory confidence.

The European Union influences global benchmarks through legally enforceable maximum levels and high demand for accredited testing. BRICS economies combine major agricultural production, large consumer markets, and growing laboratory capacity, creating broad demand for screening and confirmatory methods. G7 countries emphasize advanced instrumentation, traceability, and risk-based regulation, while NATO member markets often overlap with stringent food defense, logistics resilience, and public procurement requirements that reinforce verified food and feed safety controls.

In the United States, mycotoxin testing is driven by FDA action levels, grain merchandising standards, pet food safety, dairy aflatoxin M1 controls, and export documentation. Canada emphasizes grain quality, feed safety, and science-based surveillance, while Mexico’s maize, peanut, and feed supply chains require reliable aflatoxin and fumonisin monitoring. Brazil’s role in soy, maize, peanuts, coffee, and animal protein exports makes testing central to trade assurance.

The United Kingdom, Germany, France, Italy, and Spain operate within strict European food safety expectations, supported by accredited laboratories and routine monitoring of cereals, nuts, dried fruits, wine, coffee, and feed. Russia’s grain and feed markets require contamination control for domestic and export channels. China and India face large-scale testing needs across grains, oilseeds, spices, and dairy-linked feed chains; Japan and South Korea emphasize import compliance and high-quality analytical standards; Australia focuses on grain export integrity, feed safety, and risk management in drought-affected production systems.

Industry leaders should build risk-based mycotoxin programs that combine supplier qualification, representative sampling, rapid screening, confirmatory LC-MS/MS testing, and documented corrective actions. Testing strategies should reflect commodity risk, geography, seasonality, storage conditions, and regulatory destination rather than applying a one-size-fits-all protocol.

Companies should invest in ISO/IEC 17025-aligned laboratory partnerships, validated multi-mycotoxin panels, digital chain-of-custody, and AI-assisted risk forecasting. Feed manufacturers, grain handlers, food processors, and exporters should also integrate moisture control, storage monitoring, segregation, and detoxification policies where legally permitted to reduce contamination before it becomes a market access or consumer safety issue.

This executive summary is grounded in secondary research from recognized public authorities and standards bodies, including WHO, FAO, Codex Alimentarius, the U.S. FDA, USDA resources, the European Commission, EFSA communications, and national food safety agencies. The analysis considers established mycotoxin categories, regulated commodities, sampling principles, laboratory methods, and documented public health risks.

Market interpretation was developed through triangulation of regulatory frameworks, commodity trade patterns, laboratory technology adoption, and food safety compliance trends. The methodology prioritizes verified facts, avoids unsupported market sizing, and focuses on evidence-based implications for testing providers, food and feed manufacturers, exporters, importers, and quality assurance leaders.

Mycotoxin testing is becoming a strategic requirement for food safety, animal health, regulatory compliance, and global trade resilience. The combined pressure of climate variability, complex sourcing, tighter contaminant limits, and consumer safety expectations is increasing the need for faster, broader, and more defensible testing programs.

Organizations that integrate validated analytical methods, predictive risk intelligence, accredited laboratory practices, and proactive supplier controls will be better positioned to reduce recalls, protect brand trust, and maintain access to regulated markets. The strongest growth opportunities will favor testing ecosystems that deliver accuracy, speed, traceability, and actionable risk prevention.